# Boston Medical Center and Boston University Medical Campus IRB – FDA Inspection, Jun 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/boston-medical-center-and-boston-university-medical-campus-irb/6e35163c-d662-459b-8967-ae718dc4252f
Source feed: FDA_Inspections

> FDA inspection 1015118 of Boston Medical Center and Boston University Medical Campus IRB, June 08, 2017. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015118
- Company Name: Boston Medical Center and Boston University Medical Campus IRB
- Inspection Date: 2017-06-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1234333 - 2024-03-22
- FDA Inspection 654774 - 2010-03-26

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/boston-medical-center-and-boston-university-medical-campus-irb/f865fc79-61d0-4891-a386-7f3216e67ba0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
